What would you give for a second chance?
In 2015, Paul was hopeful and feeling positive after he was diagnosed with glioblastoma (GBM) and had started treatment. He knew it could return at any time, but had great hopes of joining the tiny 2 % of GBM patients who escape their cancer returning and are still alive after five years. After just one year towards that treasured five-year milestone his GBM is back.
Dr Brett Stringer, a scientist who, like others here at QIMR Berghofer, has dedicated his life to brain cancer research, couldn’t help feeling overcome with a sense of immense sadness and anger at this news.
We can’t yet say why it develops in some people and not others, we still don’t know if there are lifestyle factors that influence its likelihood of development. Unfortunately, what we do know is that GBM is nasty, very nasty. It will almost always recur – and when it does, treatment options are limited. Chemotherapy and radiation are mostly ineffective. There is no known cure.
As survival rates for other cancers increase, for brain cancers – and specifically GBM, they remain static. Levels of government funding to brain cancer are proportionately less than for most other cancers. But even with these factors against us QIMR Berghofer is continuing the fight against this devastating disease.
Give hope to people diagnosed with GBM
Dr Brett Stringer is part of the team at QIMR Berghofer that is forging ahead with a trial using immunotherapy technologies – equipping our own immune system with the capabilities to fight cancer. The world-first trial is based on a discovery by Professor Andrew Boyd and Dr Bryan Day, here at QIMR Berghofer. They discovered a target that is important for the growth of cancer cells. An antibody has been developed that could bind to that target and stop the growth. This trial will give us vital information about blood levels and brain penetration capabilities. We could be one step closer to finding a cure for this voracious cancer.
Your gift today could provide the missing piece of the puzzle that drives us towards finding a cure for GBM
GBM is a malicious cancer. It is aggressive, it does not discriminate, and only just 1 person in every 10 has any chance of surviving if diagnosed.
Time is of the essence. For us, for Paul, for anyone already diagnosed with brain cancer.
It’s shocking to know that even though brain cancer is nearly always terminal we still appear to be no closer to the solution… until now.
Please be part of the change and donate today.